Community
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. Please do your own research before investing.

N/A
Jun 2017 (9 Years)
Last online: No recent activity
Be the first to rate and review this company.
Provided by TrustFinance
Be the first to rate and review this company.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Warning
This company is currently Unproved.
Please be cautious of the potential risks!
License
A Grade License
Issued by globally renowned regulators, these licenses ensure the highest trader protection through strict compliance, fund segregation, insurance, and regular audits. Dispute resolution and adherence to AML/CTF standards further enhance security.
B Grade License
Granted by respected regional regulators, these licenses offer robust safety measures such as fund segregation, financial reporting, and compensation schemes. Though slightly less strict than Tier 1, they provide dependable regional protection.
C Grade License
Issued by regulators in emerging markets, these licenses offer basic protections such as minimum capital requirements and AML policies. Oversight is less stringent, so traders should exercise caution and verify safety measures.
D Grade License
From jurisdictions with minimal oversight, these licenses often lack key protections like fund segregation and insurance. While attractive for operational flexibility, they pose higher risks to traders.
TrustFinance is not a licensed financial advisor and is not affiliated with any financial institutions in your region. We encourage you to do your own research before making any investment decisions.
Get to know Zenome Platform
Company Information
Get to know Zenome Platform
Zenome Platform was a technology project that aimed to create a decentralized and secure market for genomic data using blockchain technology. The mission was to empower individuals by giving them full control and ownership over their personal genetic information, allowing them to monetize it by selling access to researchers, pharmaceutical companies, and other interested parties. The platform was designed to use its own cryptocurrency, the Zenome (ZNA) token, for all transactions, ensuring privacy and transparent compensation for data providers. The project conducted an Initial Coin Offering (ICO) in 2017-2018 but has shown no significant development or public activity since.
Industry
Reviews
Total 0
Filter
5 Star
4 Star
3 Star
2 Star
1 Star
Sort by
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis
AI Review analysis
Let’s TrustFinance AI Summarize all the reviews for you.
Provided by TrustFinance AI Analysis